Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (30)

2022

  1. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 196, Núm. 3, pp. 589-598

2021

  1. Long-term outcomes among a nationwide cohort of patients using an implantable cardioverter-defibrillator: UMBRELLA study final results

    Journal of the American Heart Association, Vol. 10, Núm. 1, pp. 1-23

  2. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

  3. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies

    Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 296-302

  4. Sex-Specific Ventricular Arrhythmias and Mortality in Cardiac Resynchronization Therapy Recipients

    JACC: Clinical Electrophysiology, Vol. 7, Núm. 6, pp. 705-715

  5. The clinical impact of untreated slow ventricular tachycardia in patients carrying implantable cardiac defibrillators

    Journal of Interventional Cardiac Electrophysiology, Vol. 62, Núm. 1, pp. 103-111

2020

  1. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood, Vol. 135, Núm. 4, pp. 274-286

  2. Patient satisfaction with remote monitoring of cardiac implantable electronic devices: The Valiosa questionnaire

    BMC Health Services Research, Vol. 20, Núm. 1

  3. Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 22, Núm. 5, pp. 704-715

  4. Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy

    ESC Heart Failure, Vol. 7, Núm. 1, pp. 279-283

  5. Trends in the implantation of single-coil vs dual-coil defibrillator leads. Data from a large Spanish cohort

    REC: CardioClinics, Vol. 55, Núm. 1, pp. 30-37

2019

  1. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas

    American Journal of Surgical Pathology, Vol. 43, Núm. 3, pp. 877-886

  2. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

  3. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices

    Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275

  4. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis

    International Journal of Cardiology, Vol. 274, pp. 163-169

2018

  1. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets

    Leukemia, Vol. 32, Núm. 3, pp. 675-684

  2. Novel double factor PGT strategy analyzing blastocyst stage embryos in a single NGS procedure

    PLoS ONE, Vol. 13, Núm. 10

  3. Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators

    Revista Espanola de Cardiologia, Vol. 71, Núm. 9, pp. 709-717

  4. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial

    European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264

2017

  1. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy

    Europace, Vol. 19, Núm. 11, pp. 1818-1825